Dental Care Clinics in West Boylston, MA Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 West Boylston Dental Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 71 Central St, West Boylston, MA 01583 Phone: 508-835-3146 |
Tony Saito, Dmd, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 67 W Boylston St, West Boylston, MA 01583 Phone: 508-835-6752 |
Eero A Aijala Dmd Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 244 West Boylston Street, Suite 9, West Boylston, MA 01583 Phone: 508-835-4926 Fax: 978-464-5065 |
Taher Family Dental Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 32 W Boylston St, West Boylston, MA 01583 Phone: 508-835-2525 |
Christos G. Kirusis, Dmd., Pc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1 Prescott St, West Boylston, MA 01583 Phone: 508-835-8890 Fax: 508-835-8960 |
News Archive
For older people, the risks outweigh the benefits of taking sleeping pills and other sedatives
Insomnia can often affect the quality of life for older people and between 5% and 33% of older people in the UK are prescribed sleeping pills such as benzodiazepine.
Depression and anxiety during childhood linked to higher BMI into adulthood for women but not men
The increasing prevalence of obesity among children and adults is becoming a public health crisis, according to background information in the article.
Medical tourism in Latin America requires regulation: University of Montreal researchers
Medical tourism in Latin America needs to be regulated to protect consumers, according to Universit- de Montr-al researchers. A new study published in the journal Developing World Bioethics argues that Argentinean fertility clinics are increasingly marketing themselves to international health care consumers: these clinics offer all-inclusive packages with fixed prices that feature airfare, accommodations, transfers, language interpreters and, of course, fertility treatments.
Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma
Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.
› Verified 1 days ago